
    
      Participants received intramuscular injections of palivizumab according to physicians'
      prescription and the local label. The local label recommended 1 month injection intervals
      between 5 sequential injections at a dose of 15 mg/kg. Participants could have received from
      3 to 5 monthly injections of palivizumab during the 2014 - 2015 RSV season and the duration
      of this study.
    
  